BICNU 100 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSION EFG

( ARTG ) INDICATIONS AS AT 16 DECEMBER 1985: Carmustine is indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: 1. Malignant Glioma. 2. Multiple Myeloma: In combination with prednisone. 3. Hodgkin's Disease: As secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy. 4. Non-Hodgkins lymphomas: As secondary therapy in combination with other approved drugs for patients who relapse while being treated with primary therapy or who fail to respond to primary therapy.